Biography

Prof. Mehdi Hamadani

West Virginia University, USA


Email: mehdi.hamadani@gmail.com


Qualifications


1995 M.Sc., King Edward Medical College

1993 B.Sc., Government College


Publications (selected)

  1. Pant S., Hamadani M., Dodds AJ., Szer J., Crilley PA., Stevenson D., Phillips G., Elder P, Nivison-Smith I, Avalos BR., Penza S., Topolsky D., Sobecks R., Kalaycio M., Bolwell BJ., Copelan EA.: “Incidence and reasons for late failure after allogeneic hematopoietic cell transplantation following BuCy2 in acute myeloid leukemia.” Br J Haematol. 2010 February;148(4):623-626. Epub 2009 October 11.
  2. Benson DM Jr., Panzner K., Hamadani M., Hofmeister CC., Bakan CE., Smith MK., Elder P., Krugh D., O’Donnell L., and Devine SM.: “Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.” Leuk Lymphoma. 2010 Februrary;51(2):243-251. Epub 2009 December 28.
  3. Hamadani M., Awan FT.: "Remission induction, consolidation and novel agents in development for adults with acute myeloid leukemia." Hematol Oncol. 2010 March;28(1):3-12. Epub 2009 July 31.
  4. Christian B., Zhao W., Hamadani M., Sotomayor, EM., Narvarro W., Devine SM., Racke F., Blum KA.: “Mantle cell lymphoma twelve years after allogeneic bone marrow transplant occurring simultaneously in recipient and donor.” J Clin Oncol. 2010 November;28(31):e629-632. Epub 2010 Aug 23.
  5. Hamadani M., Craig M., Awan FT., Devine SM.: “How we approach patient evaluation for hematopoietic stem cell transplantation.” Bone Marrow Transplant. 2010 August;45(8):1259-1268. Epub 2010 May 17.
  6. Awan FT., Osman S., Kochuparambil ST., Gibson L., Remick SC., Abraham J., Craig M., Jillella A., Hamadani M.: “Impact of response to thalidomide, lenalidomide or bortezomib containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation.” Bone Marrow Transplant. 2012 January;47(1):146-148. Epub 2011 Feb 28.
  7. Hamadani M., Craig M., Phillips G., Abraham J., Tse W., Cumpston C., Gibson L., Remick S., Hofmeister C., Penza S., Efebera Y., Andritsos L., Garzon R., Benson D., Blum W., Devine SM.: “Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic hematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.” Hematol Oncol. 2011 December;29(4):202-210. Epub 2011 Feb 28.
  8. Hamadani M., Craig M., Gibson L., Remick S.: “The evolving role of statins in hematopoietic stem and progenitor cell transplantation.” Am J Blood Res. 2011 June;1(1):57-64.
  9. Kumar S., Zhang M., Li P., Dispenzieri A., Milone G., Lonial S., Krishnan A., Maiolino A., Wirk B., Weiss B., Freytes C., Vogl D., Vesole D., Lazarus H., Meehan K., Hamadani M., Lill M., Callander N., Majhail N., Wiernik P., Nath R., Kamble R., Vij R., Kyle R., Gale R., Hari P.: “Trends in allogeneic stem cell transplantation for multiple myeloma: a center for international blood and marrow transplant research (CIBMTR) analysis.” Blood. 2011 Aug;118(7)1979-1988. Epub 2011 Jun 20.
  10. Liu K., Anthony BA., Liu K., Yearsly MM., Hamadani M., Devine SM., Hadley GA.: “CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.” PLoS One. 2011;6(7): e21968. Epub 2011 Jul 14.
  11. Kanate AS., Craig M., Cumpston A., Saad A., Hobbs G., Leadmon S., Bunner P., Watkins K., Bulian D., Gibson L., Abraham J., Remick SC., Hamadani M.: “Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not T-cell replete allogeneic peripheral blood hematopoietic cell transplantation.” Hematol Oncol Stem Cell Ther. 2011;4(4):149-156.
  12. Hamadani M., Kochuparambil ST., Osman S., Cumpston A., Leadmon S., Bunner P., Watkins K., Morrison D., Speir E., DeRemer D., Kota V., Jillella A., Craig M., Awan F.: “Intermediate- versus low-dose cyclophosphamide and granulocyte colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma patients treated with novel induction therapies.” Biol Blood Marrow Transplant. 2012 Jul;18(7)1128-1135. Epub 2012 Jan 13.
  13. Sweet M., Cumpston C., Briggs F., Craig M., Hamadani M.: “Impact of alcohol impregnated port protectors and needleless neutral pressure connectors on central line-associated blood stream infections and contamination of blood cultures in an inpatient hematology and oncology unit.” Am J Infect Control. Epub 2012 May 8.
  14. Awan F., Kochuparambil ST., DeRemer D., Cumpston A., Craig M., Jillella A., Hamadani M.: "Plerixafor salvage is safe and effective in hard-to-mobilize patients undergoing chemotherapy and filgrastim-based peripheral blood progenitor cell mobilization." J Oncol. 2012;2012: 931071. Epub 2012 Apr 10.
  15. Ranganathan P., Heaphy C., Costinean S., Stauffer N., Na C., Hamadani M., Santhanam R., Mao C., Taylor P., Sandhu S., He G., Shana'ah A., Nuovo G., Obad S., Broom O., Kauppinen S., Byrd JC.,
  16. Caligiuri M., Perotti D., Hadley G., Marcucci G., Devine M., Blazar B., Croce C., Garzon R.: “Regulation of acute graft-versus-host disease by microRNA-155.” Blood. 2012 May;119(20)4786-4797. Epub 2012 Mar 9.
  17. Ballen KK., Woolfrey A., Zhu X, Ahn K., Wirk B., Arora M., George B., Savani B., Bolwell B., Porter D., Copelan E., Hale G., Schouten H., Lewis I., Cahn J., Halter J., Cortes J., Kalaycio M., Antin J., Aljurf M., Carabasi M., Hamadani M., McCarthy P., Pavletic S., Gupta V., Deeg H., Maziarz R., Horowitz M., Saber W.: “Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.” Biol Blood Marrow Transplant. In Press. Epub 2012 Mar 23.
  18. Hamadani M., Devine SM.: “Patient evaluation before transplantation (adult).” In: Wingard JR, Gastineau D, Leather H, Snyder EL, Szczepiorkowski ZM, eds. Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians, 1st ed. Bethesda, MD: AABB Press; 2009: 27-43.
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top